ATOSSA THERAPEUTICS, INC. (ATOS)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $33k
- Nov 15 · Unusual
- Form 4 sales
- 4
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Timeline
- 1 Form 4 salePlan not statedOct 1 2013
Sold 7,265 shares at $5.66 ($41k)
Chen Shu-Chih, Chief Scientific Officer
Sold 0.2% of holdings ($24.2M position)4.3M shares leftFirst sale on recordFiling
- 2 Form 4 salePlan not statedOct 1 same day
Sold 7,265 shares at $5.66 ($41k)
Quay Steven C, CEO
Sold 0.2% of holdings ($24.2M position)4.3M shares leftFirst sale on recordFiling
- 3 Form 4 saleUnusualJul 2 +2831 days
Sold 107,497 shares at $5.58 ($600k)
Weaver Gregory L, Director
Sold 100% of holdings ($600k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 saleUnusualNov 15 +866 days
Sold 50,000 shares at $0.65 ($33k)
Weaver Gregory L, Former EVP, CFO, & Director
No 10b5-1 planSold 99.9% of holdings ($33k position)55 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (4)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Weaver Gregory L | Former EVP, CFO, & Director | Form 4 sale | 50,000 | $33k | 99.9% | Unusual | SEC |
| Jul 2, 2021 | Weaver Gregory L | Director | Form 4 sale | 107,497 | $600k | 100.0% | Unusual | SEC |
| Oct 1, 2013 | Quay Steven C | CEO | Form 4 sale | 7,265 | $41k | 0.2% | Plan not stated | SEC |
| Oct 1, 2013 | Chen Shu-Chih | Chief Scientific Officer | Form 4 sale | 7,265 | $41k | 0.2% | Plan not stated | SEC |